Reacción a " Polyendocrine metabolic ovarian syndrome is associated with a higher risk of cardiovascular events"

I believe this is an important study, particularly given the large number of women included and the duration of the follow-up. The results reinforce the idea that SOMP is not merely a problem related to menstruation, fertility or the ovaries, but a condition with metabolic and cardiovascular implications. The increased risk they have identified is striking and remains even after taking into account factors such as obesity, high blood pressure, diabetes and high cholesterol.

Nevertheless, it must be interpreted with some caution. As this is a study based on administrative records, there may be errors in the identification of certain diagnoses, and it does not allow a causal relationship to be demonstrated. Furthermore, although the relative risk increases significantly, the absolute risk in young women remains low. In practice, the message should not be to cause alarm, but rather to emphasise that these women require metabolic and cardiovascular assessment from the time of diagnosis and long-term follow-up. The new name, SOMP, fits well with this broader view of the syndrome, although it should not make us forget that this is a highly heterogeneous condition.